ARTICLE | Clinical News
Nexium esomeprazole sodium regulatory update
April 11, 2005 7:00 AM UTC
FDA approved an sNDA for an IV formulation of Nexium for the short-term treatment (up to 10 days) of gastroesophageal reflux disease (GERD) patients with a history of erosive esophagitis and unable to...